Quarterly report pursuant to Section 13 or 15(d)

NOTES PAYABLE (Details Narrative)

v3.10.0.1
NOTES PAYABLE (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended
Apr. 18, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2016
Dec. 31, 2017
Convertible promissory notes, offering total $ 2,500,000        
Derivative liability       $ 13,508
Extinguishment of related party debt and derivative liability as contributed capital   $ 13,508    
Maximum [Member]          
Royalty liability 11,500,000        
Private Placement [Member]          
Convertible promissory notes, offering total $ 11,500,000        
Interest rate 7.50%        
Notes conversion description   Common stock, equal to 30% of the value of their original convertible note.      
Warrants issued to purchase common shares   230,940      
Warrants issued to purchase common shares, value   $ 3,334      
Private Placement [Member] | Convertible Notes [Member]          
Convertible promissory notes principal amount       $ 1,382,000  
Interest rate       7.50%  
Common stock, convertible conversion, percentage       90.00%  
Notes maturity period       24 months  
Notes conversion description      

The notes mature 24 months after issuance, if not converted prior to the maturity date, the notes automatically convert into shares of common stock of the Company at a per share price equal to 80% of the closing bid price of the common stock of the Company during the 20 consecutive trading days immediately preceding the maturity date. The holders of the notes will receive, in the aggregate, pro rata based on investment, a total of five percent of the revenues of Caretta Therapeutics, LLC during the years ending December 31, 2017, 2018, 2019 and 2020. The investors shall also receive warrants to purchase a number of shares equal to 30% of the amount invested, for a period of two years, at an exercise price per share equal to 110% of the closing bid price of the common stock of the Company on the six-month anniversary of the date of issuance of such warrant.

 
Warrants issued to purchase common shares   626,185      
Warrants issued to purchase common shares, value   $ 32,557      
Exercise price per share   $ 1.30      
Warrant term   3 years      
Private Placement [Member] | Convertible Notes [Member] | Maximum [Member]          
Convertible promissory notes, offering total       $ 2,500,000  
Private Placement 2017 [Member] | Convertible Notes [Member]          
Convertible promissory notes principal amount   $ 769,800      
Convertible notes, converted, shares   74,973      
Convertible notes, converted, value   $ 25,000      
Convertible notes, fair value   21,742      
Extinguishment of related party debt and derivative liability as contributed capital   13,508      
Private Placement 2017 [Member] | Convertible Notes [Member] | Royalty Liability [Member]          
Debt discount   623,405      
Private Placement 2017 [Member] | Convertible Notes [Member] | Warrant [Member]          
Debt discount   $ 3,334